Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""PROGNOSIS"" wg kryterium: Temat


Starter badań:

Tytuł :
Regression to the mean, heteroscedasticity, and prognostic imbalance in randomized controlled trials: a call for graphical methods.
Autorzy :
Schelly D; Department of Occupational Therapy, Clarkson University, Potsdam, NY, United States.
Pokaż więcej
Źródło :
Pain [Pain] 2022 Aug 01; Vol. 163 (8), pp. 1464-1467. Date of Electronic Publication: 2021 Dec 03.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Computer Simulation ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Effect modification in a clinical trial should be assessed through interaction terms, not prognostic modelling.
Autorzy :
Roepke RML; Trauma and Acute Care Surgery ICU, Department of Surgery, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.; Intensive Care Unit, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Mendes PV; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Cardozo Junior LCM; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Park M; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Besen BAMP; Intensive Care Unit, A.C. Camargo Cancer Center, São Paulo, SP, Brazil. .; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 11th Floor, Room 11083, São Paulo, SP, 05403-000, Brazil. .
Pokaż więcej
Źródło :
Intensive care medicine [Intensive Care Med] 2022 Aug; Vol. 48 (8), pp. 1122-1124. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prognosis*
Humans
Opinia redakcyjna
Tytuł :
 
Autorzy :
Fath R; Redaktionsbüro focusmed, Freier Medizinjournalist, Eidelstedter Weg 118, 20255, Hamburg, Germany. .
Pokaż więcej
Transliterated Title :
Prognose verbessern.
Źródło :
MMW Fortschritte der Medizin [MMW Fortschr Med] 2022 Aug; Vol. 164 (14), pp. 74.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Humans
Czasopismo naukowe
Tytuł :
Prognostic analysis of hidradenocarcinoma: a SEER-based observational study.
Autorzy :
Gao T; Department of Dermatology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Pan S; Department of Dermatology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Li M; Department of Dermatology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Su R; Department of Neurology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Pokaż więcej
Źródło :
Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 454-463.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Prognosis*
Humans ; SEER Program ; Survival Analysis ; Survival Rate
Czasopismo naukowe
Tytuł :
QUAPAS: An Adaptation of the QUADAS-2 Tool to Assess Prognostic Accuracy Studies.
Autorzy :
Lee J; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands (J.L., M.L., P.M.B.).
Mulder F; Department of Vascular Medicine, Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands (F.M.).
Leeflang M; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands (J.L., M.L., P.M.B.).
Wolff R; Kleijnen Systematic Reviews, Escrick, United Kingdom (R.W.).
Whiting P; Bristol Medical School, University of Bristol, Bristol, United Kingdom (P.W.).
Bossuyt PM; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands (J.L., M.L., P.M.B.).
Pokaż więcej
Źródło :
Annals of internal medicine [Ann Intern Med] 2022 Jul; Vol. 175 (7), pp. 1010-1018. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Prognosis*
Bias ; Humans ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
[END-OF-LIFE PROGNOSTICATION IN ACUTE HOSPITAL PALLIATIVE PATIENTS: IS THE PALLIATIVE PERFORMANCE SCALE USEFUL?]
Autorzy :
Cohen K; Palliative Care Service, Emek Medical Center. Afula, Israel.
Paz E; Intensive Care and Palliative Care, PC Service, Emek Medical Center. Afula, Israel.
Pokaż więcej
Źródło :
Harefuah [Harefuah] 2022 May; Vol. 161 (5), pp. 304-310.
Typ publikacji :
Journal Article
MeSH Terms :
Palliative Care*
Prognosis*
Death ; Hospitals ; Humans ; Neoplasms ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response.
Autorzy :
Wang C; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
Feng G; Big Data & Engineering Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
Zhu J; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Wei K; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Huang C; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Wu Z; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Yu Y; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Qin G; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
Pokaż więcej
Źródło :
Future oncology (London, England) [Future Oncol] 2022 Mar; Vol. 18 (9), pp. 1055-1066. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Prognosis*
Immune Checkpoint Inhibitors/*therapeutic use
Triple Negative Breast Neoplasms/*drug therapy
Biomarkers, Tumor ; Female ; Humans ; Middle Aged ; Proportional Hazards Models ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/mortality
Czasopismo naukowe
Tytuł :
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies.
Autorzy :
Foroutan F; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada. Electronic address: .
Guyatt G; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Trivella M; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; School of Medicine, Keele University, Keele, United Kingdom.
Kreuzberger N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Skoetz N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Riley RD; School of Medicine, Keele University, Keele, United Kingdom.
Roshanov PS; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK.
Alba AC; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada.
Sekercioglu N; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Canelo-Aybar C; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Iberoamerican Cochrane Centre - Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025 Barcelona, Spain.
Munn Z; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; School of Medicine, Keele University, Keele, United Kingdom.
Brignardello-Petersen R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Schünemann HJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Iorio A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Pokaż więcej
Źródło :
Journal of clinical epidemiology [J Clin Epidemiol] 2022 Mar; Vol. 143, pp. 202-211. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Calibration ; Forecasting ; Humans ; Probability
Czasopismo naukowe
Tytuł :
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
Autorzy :
Delahunt B; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: .
Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand.
Christie D; Genesis Care, Tugun, Qld, Australia.
Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia.
Egevad L; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia.
Kenwright DN; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Matthews J; Auckland City Hospital, Auckland, New Zealand.
Murray JD; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Samaratunga H; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.
Spry NA; Genesis Care, Perth, WA, Australia.
Thunders MC; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Hondermarck H; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia.
Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Pokaż więcej
Źródło :
Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 49-54. Date of Electronic Publication: 2021 Dec 24.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Adenocarcinoma/*pathology
Prostatic Neoplasms/*pathology
Biopsy, Large-Core Needle ; Humans ; Male ; Neoplasm Grading/methods ; Prostate/pathology ; Prostatectomy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The prognostic significance of pleomorphism in gastrointestinal stromal tumours.
Autorzy :
Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Histopathology [Histopathology] 2022 Feb; Vol. 80 (3), pp. 598-603. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Biomarkers, Tumor/*genetics
Gastrointestinal Stromal Tumors/*genetics
Intestine, Small/*pathology
Mutation/*genetics
Stomach Neoplasms/*pathology
Female ; Humans ; Immunohistochemistry ; Longitudinal Studies ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Probing patterns for prognostic potential.
Autorzy :
Levine SM; Department of Psychology, LMU Munich, Leopoldstraße 13, 80802, Munich, Germany. .; NeuroImaging Core Unit Munich (NICUM), University Hospital LMU, Nußbaumstraße 7, 80336, Munich, Germany. .
Pokaż więcej
Źródło :
Translational psychiatry [Transl Psychiatry] 2022 Apr 21; Vol. 12 (1), pp. 167. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prognosis*
Opinia redakcyjna
Tytuł :
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma.
Autorzy :
Schneider MA; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Richtmann S; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Gründing AR; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Wrenger S; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Welte T; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Meister M; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Kriegsmann M; Translational Research Center Heidelberg (TLRC), Member of The German Center for Lung Research (DZL), D-69120 Heidelberg, Germany.
Winter H; Translational Research Center Heidelberg (TLRC), Member of The German Center for Lung Research (DZL), D-69120 Heidelberg, Germany.
Muley T; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Janciauskiene S; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Pokaż więcej
Źródło :
International journal of oncology [Int J Oncol] 2022 Apr; Vol. 60 (4). Date of Electronic Publication: 2022 Feb 25.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Adenocarcinoma of Lung/*diagnosis
Serine Endopeptidases/*analysis
Adenocarcinoma of Lung/blood ; Adenocarcinoma of Lung/genetics ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/blood ; Cell Line, Tumor ; Humans ; Serine Endopeptidases/blood
Czasopismo naukowe
Tytuł :
Volumetric Splenomegaly in Patients With Polycythemia Vera.
Autorzy :
Lee MW; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yeon SH; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Ryu H; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yun HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Kim SY; Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee JE; Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
Shin KS; Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
Jo DY; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea. .
Pokaż więcej
Źródło :
Journal of Korean medical science [J Korean Med Sci] 2022 Mar 21; Vol. 37 (11), pp. e87. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :
Journal Article
MeSH Terms :
Predictive Value of Tests*
Prognosis*
Polycythemia Vera/*complications
Splenomegaly/*diagnosis
Splenomegaly/*etiology
Splenomegaly/*physiopathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Republic of Korea ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Autorzy :
Pan XQ; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Huang W; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jin LW; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lin HZ; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xu XY; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Mar 09; Vol. 2022, pp. 8093837. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Profiling*
Prognosis*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Pyroptosis/*genetics
Computational Biology ; Databases, Genetic ; Female ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Transcriptome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
Autorzy :
Guo H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Jiang S; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Sun H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Shi B; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Li Y; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Zhou N; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Zhang D; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Guo H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Mar 08; Vol. 2022, pp. 9443407. Date of Electronic Publication: 2022 Mar 08 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Receptors, Interleukin*
Transcriptome*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Cell Line, Tumor ; Computational Biology ; Humans ; Survival Analysis ; Tumor Microenvironment ; Up-Regulation
Czasopismo naukowe
Tytuł :
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Autorzy :
Reig M; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: .
Forner A; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain.
Rimola J; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ferrer-Fàbrega J; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Burrel M; BCLC Group, Vascular Department, CDI, Hospital Clinic of Barcelona, Barcelona University, University of Barcelona, Barcelona, Spain.
Garcia-Criado Á; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Galle PR; Department of Internal Medicine, Mainz University Medical Center, Mainz, Germany.
Mazzaferro V; Department of Oncology, University of Milan and HPB Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Salem R; Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL, USA.
Sangro B; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain.
Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vogel A; Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany.
Fuster J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ayuso C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Bruix J; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: .
Pokaż więcej
Źródło :
Journal of hepatology [J Hepatol] 2022 Mar; Vol. 76 (3), pp. 681-693. Date of Electronic Publication: 2021 Nov 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Prognosis*
Carcinoma, Hepatocellular/*classification
Carcinoma, Hepatocellular/complications ; Female ; Humans ; Liver Neoplasms/classification ; Liver Neoplasms/complications ; Male ; Middle Aged ; Neoplasm Staging/methods ; Neoplasm Staging/statistics & numerical data ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.
Autorzy :
Xu J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Chen W; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Sun Z; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Peng H; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Zhou C; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Pan S; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 24; Vol. 2022, pp. 5470166. Date of Electronic Publication: 2022 Feb 24 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/pathology
Prognosis*
Cell-Free Nucleic Acids/*genetics
DNA Copy Number Variations/*genetics
Mutation/*genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Middle Aged ; Mucin-1
Czasopismo naukowe
Tytuł :
Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
Autorzy :
Zhao S; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.; School of Clinical Medicine, The Guizhou Medical University, Guiyang, Guizhou, China.
Jiang H; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Liu J; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Li DY; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Li B; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Long QR; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Zheng L; Shenzhen Eye Hospital, Shenzhen, 5180403 Guangdong, China.
Gu H; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 23; Vol. 2022, pp. 5994800. Date of Electronic Publication: 2022 Feb 23 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Disease-Free Survival*
Prognosis*
Enhancer Elements, Genetic/*genetics
Melanoma/*genetics
Uveal Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Male ; Nerve Tissue Proteins
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies